Correction to: Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.

Amy A Kirkham, D Ian Paterson, Carla M Prado, John R Mackey, Kerry S Courneya, Edith Pituskin, Richard B Thompson

Abstract readPublished Erratum

In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

Erratum for
Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.2018

5 · Who and what money

Authors and funding

7 authors.

Amy A KirkhamDepartment of Biomedical Engineering, University of Alberta, 1098 ResearchTransition Facility, 8308-114 Street, Edmonton, AB, T6G 2V2, Canada. amy.kirkham@ualberta.ca.

D Ian PatersonDepartment of Medicine, Division of Cardiology, University of Alberta, Edmonton, Canada.

Carla M PradoDepartment of Agricultural, Food & Nutrition Science, University of Alberta, Edmonton, Canada.

John R MackeyDepartment of Oncology, University of Alberta, Edmonton, Canada.

Kerry S CourneyaFaculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, Canada.

Edith PituskinFaculty of Nursing, University of Alberta, Edmonton, Canada.

Richard B ThompsonDepartment of Biomedical Engineering, University of Alberta, 1098 ResearchTransition Facility, 8308-114 Street, Edmonton, AB, T6G 2V2, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly.

Identifiers

PMID30646862

DOI10.1186/s12885-019-5298-9

PMCPMC6334459

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.